PVLA

Palvella Therapeutics, Inc.

PVLA·697947109·US·Common Stock·Healthcare - Biotechnology-13D/G

PVLA (Palvella Therapeutics, Inc.) is held by 114 institutional investors as of Q2 2026. Largest holders: JENNISON ASSOCIATES LLC ($146.8M), BlackRock, Inc. ($140.3M), STATE STREET CORP ($99.8M). Net institutional sentiment: Bullish.

114
Holders
(12 Elite)
$1.1B
Total Value
71% (111)
Consensus
79 buying - 32 selling
13F: Insider & Congress: Updated regularly
PVLA

Smart Money Verdict

View all
Loading verdict
Held by 114 funds
12 elite

Who's Trading

Source dates: Price Aug 27, 2026 · Insiders Aug 20, 2026 · Activists Aug 14, 2026 · Congress none

InsiderGKGoin KathleenSell $16KAug 19, 2026
InsiderGKGoin KathleenExercise 2K shAug 19, 2026
InsiderGKGoin KathleenSell $61KAug 19, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
960,619(+50.0%)$146.8M0.1%+26.85%
42
Increased
918,357(+33.7%)$140.3M0.0%+96.15%
39
Increased
653,172(+42.3%)$99.8M0.0%+47.48%
40
Increased
513,794(+7.7%)$78.5M0.0%+16.02%
32
Increased
478,833(+28.0%)$73.2M0.7%+13.33%
52
Unchanged
433,015$66.2M0.1%+105.33%
0
Unchanged
317,517$48.5M0.1%+407.41%
0
Increased
276,164(+34.3%)$42.2M0.0%+119.61%
38
Increased
256,182(+31.4%)$39.1M0.0%+12.98%
37
Decreased
214,841(-0.5%)$32.8M0.0%+88.37%
0
Decreased
253,168(-3.7%)$31.6M0.0%+54.52%
0
Increased
201,514(+3.8%)$30.8M0.0%+68.84%
30
Increased
181,428(+41.8%)$27.7M0.0%+89.21%
38
Increased
128,962(+41.9%)$19.7M0.0%+11.99%
38
Increased
120,238(+48.3%)$18.4M0.0%+11.47%
39
Increased
97,193(+51.0%)$14.9M0.0%+95.93%
39
Increased
83,107(+69.3%)$12.7M0.0%+25.33%
41
Increased
73,995(+14.2%)$11.3M0.0%+15.03%
32
Decreased
72,526(-30.6%)$11.1M0.0%+46.27%
0
Decreased
67,469(-3.5%)$10.3M0.0%+40.38%
0

Showing 1-20 of 120

1 / 6
PVLAPVLAPalvella Therapeutics, Inc.

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used